Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice

Autor: Kosala N. Dissanayake, Nicolas W. Martinez, Felipe A. Court, Douglas J. Lamont, Alannah J. Mole, Richard R. Ribchester, Lyndsay M. Murray, Rachel A. Kline, Thomas M. Wishart, Maria del carmen Llavero hurtado, Alexander Ahl
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Proteomics
0301 basic medicine
ETC
Electron Transport Chain

Wallerian degeneration
MPS
Mammalian Physiological Saline

Bioenergetics
P
Post Natal Day

Degeneration (medical)
2H3
Neurofilament

Mitochondrion
DRG
Dorsal Root Ganglion

Oxidative Phosphorylation
Wallerian
WD
Wallerian Degeneration

Mice
Neonate
0302 clinical medicine
Axon
TMT
Tandem Mass Tagging

Neurodegeneration
ROS
Reaction Oxygen Species

Mitochondria
medicine.anatomical_structure
Neurology
Axon degeneration
Neuromuscular Junction
AMPK
Adenosine Monophosphate Kinase

Oxidative phosphorylation
Biology
Article
Neuromuscular junction
lcsh:RC321-571
03 medical and health sciences
medicine
Animals
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
SV2
Synaptic Vesicle Protein 2

IPA
Ingenuity Pathway Analysis

OXPHOS
Oxidative Phosphorylation

NMJ
Neuromuscular Junction

TEAB
Tetraethylammonium Bromide

NMJ
QFWB
Quantitative Fluorescent Western Blotting

DHE
Dihydroethidium

ELISA
Enzyme Link Immuno

medicine.disease
Mice
Inbred C57BL

TMT-QMS
Tandem-Mass Tagging Quantitative Mass Spectrometry

030104 developmental biology
Animals
Newborn

Wallerian Degeneration
Neuroscience
030217 neurology & neurosurgery
Zdroj: Kline, R, Dissanayake, K, Llavero hurtado, M D C, Martínez, N W, Ahl, A, Mole, A J, Lamont, D J, Court, F A, Ribchester, R, Wishart, T & Murray, L 2019, ' Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice. ', Neurobiology of disease, vol. 130, 104496 . https://doi.org/10.1016/j.nbd.2019.104496
Neurobiology of Disease
Neurobiology of Disease, Vol 130, Iss, Pp 104496-(2019)
Popis: Neurodegenerative and neuromuscular disorders can manifest throughout the lifespan of an individual, from infant to elderly individuals. Axonal and synaptic degeneration are early and critical elements of nearly all human neurodegenerative diseases and neural injury, however the molecular mechanisms which regulate this process are yet to be fully elucidated. Furthermore, how the molecular mechanisms governing degeneration are impacted by the age of the individual is poorly understood. Interestingly, in mice which are under 3 weeks of age, the degeneration of axons and synapses following hypoxic or traumatic injury is significantly slower. This process, known as Wallerian degeneration (WD), is a molecularly and morphologically distinct subtype of neurodegeneration by which axons and synapses undergo distinct fragmentation and death following a range of stimuli. In this study, we first use an ex-vivo model of axon injury to confirm the significant delay in WD in neonatal mice. We apply tandem mass-tagging quantitative proteomics to profile both nerve and muscle between P12 and P24 inclusive. Application of unbiased in silico workflows to relevant protein identifications highlights a steady elevation in oxidative phosphorylation cascades corresponding to the accelerated degeneration rate. We demonstrate that inhibition of Complex I prevents the axotomy-induced rise in reactive oxygen species and protects axons following injury. Furthermore, we reveal that pharmacological activation of oxidative phosphorylation significantly accelerates degeneration at the neuromuscular junction in neonatal mice. In summary, we reveal dramatic changes in the neuromuscular proteome during post-natal maturation of the neuromuscular system, and demonstrate that endogenous dynamics in mitochondrial bioenergetics during this time window have a functional impact upon regulating the stability of the neuromuscular system.
Graphical abstract Unlabelled Image
Highlights • There is a decrease in the rate of injury induced Wallerian degeneration in motor axons aged P24. • There is a continuous increase in oxidative phosphorylation proteins from P12 to P24 in lumbrical muscle and tibial nerve. • Inhibition of complex I prevents axon degeneration following injury, and prevents the rise in reactive oxygen species. • Pharmacological activation of oxidative phosphorylation accelerates axonal and synaptic degeneration in neonatal mice. • Pharmacological inhibition of complex 1 protects axons from injury induced degeneration.
Databáze: OpenAIRE